Literature DB >> 21622002

Synthesis, conformation and biology of naphthoxylosides.

Anna Siegbahn1, Ulrika Aili, Agata Ochocinska, Martin Olofsson, Jerk Rönnols, Katrin Mani, Göran Widmalm, Ulf Ellervik.   

Abstract

Proteoglycans (PG) are polyanionic proteins consisting of a core protein substituted with carbohydrate chains, that is, glycosaminoglycans (GAG). The biosynthesis of GAG can be manipulated by simple xylosides carrying hydrophobic aglycons, which can enter the cell and initiate the biosynthesis. While the importance of the aglycon is well investigated, there is far less information on the effect of modifications in the xylose residue. We have developed a new synthetic protocol, based on acetal protection and selective benzylation, for modification of the three hydroxyl groups in xylose. Thus we have synthesized twelve analogs of 2-naphthyl β-d-xylopyranoside (XylNap), where each hydroxyl group has been epimerized or replaced by methoxy, fluoro, or hydrogen. To gain more information about the properties of xylose, conformational studies were made on some of the analogs. It was found that the (4)C(1) conformation is highly predominant, accompanied by a nonnegligible population of the (2)S(0) conformation. However, deoxygenation at C3 results in a large portion of the (1)C(4) conformation. The GAG priming ability and proliferation activity of the twelve analogs, were investigated using a matched pair of human breast fibroblasts and human breast carcinoma cells. None of the analogs initiated the biosynthesis of GAG, but an inhibitory effect on endogenous PG production was observed for analogs fluorinated or deoxygenated at C4. From our data it seems reasonable that all three hydroxyl groups in XylNap are essential for the priming of GAG chains and for selective toxicity for tumor cells.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21622002     DOI: 10.1016/j.bmc.2011.05.007

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  3 in total

1.  Probing the acceptor active site organization of the human recombinant β1,4-galactosyltransferase 7 and design of xyloside-based inhibitors.

Authors:  Mineem Saliba; Nick Ramalanjaona; Sandrine Gulberti; Isabelle Bertin-Jung; Aline Thomas; Samir Dahbi; Chrystel Lopin-Bon; Jean-Claude Jacquinet; Christelle Breton; Mohamed Ouzzine; Sylvie Fournel-Gigleux
Journal:  J Biol Chem       Date:  2015-01-07       Impact factor: 5.157

2.  Enzymatic fine-tuning for 2-(6-hydroxynaphthyl) β-D-xylopyranoside synthesis catalyzed by the recombinant β-xylosidase BxTW1 from Talaromyces amestolkiae.

Authors:  Manuel Nieto-Domínguez; Alicia Prieto; Beatriz Fernández de Toro; Francisco Javier Cañada; Jorge Barriuso; Zach Armstrong; Stephen G Withers; Laura I de Eugenio; María Jesús Martínez
Journal:  Microb Cell Fact       Date:  2016-10-04       Impact factor: 5.328

3.  Saccharide Primers Comprising Xylosyl-Serine Primed Phosphorylated Oligosaccharides Act as Intermediates in Glycosaminoglycan Biosynthesis.

Authors:  Yuya Otsuka; Toshinori Sato
Journal:  ACS Omega       Date:  2017-07-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.